In prostate cancer, liver cancer and other cancers, the expression of KLF6 is significantly decreased, and KLF6 overexpression inhibits the progression of the above-mentioned tumors, and promotes tumor cell apoptosis [14,15]. Here, KLF6 is linked to prostate carcinoma.